Add Yahoo as a preferred source to see more of our stories on Google. The early-stage pipeline for amyotrophic lateral sclerosis drugs exploded last year. After ALS R&D notched 28 new trial starts in ...
ARLINGTON, Va., Dec. 4, 2025 /PRNewswire/ -- The ALS Association is pleased to announce the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each ...
Amyotrophic lateral sclerosis (ALS) is a rare nervous system disease that destroys motor neuron cells in the spinal cord and brain. This cell damage leads to loss of muscle weakness, loss of mass, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results